Boston Scientific announces conference call discussing first quarter 2025 results
Boston Scientific (NYSE: BSX) has scheduled a conference call to discuss its first quarter 2025 financial results and business highlights on Wednesday, April 23, 2025, at 8:00 a.m. ET. The company will release its Q1 financial results prior to the call on the same day.
The conference call will be led by Mike Mahoney, chairman and CEO, alongside Dan Brennan, executive vice president and CFO. Investors and interested parties can access the live webcast and replay through the company's investor relations website.
Boston Scientific (NYSE: BSX) ha programmato una conferenza telefonica per discutere i risultati finanziari e i punti salienti del primo trimestre 2025 il mercoledì 23 aprile 2025, alle 8:00 ET. L'azienda pubblicherà i risultati finanziari del Q1 prima della chiamata nello stesso giorno.
La conferenza telefonica sarà condotta da Mike Mahoney, presidente e CEO, insieme a Dan Brennan, vicepresidente esecutivo e CFO. Gli investitori e le parti interessate possono accedere alla diretta web e alla registrazione attraverso il sito web delle relazioni con gli investitori dell'azienda.
Boston Scientific (NYSE: BSX) ha programado una llamada de conferencia para discutir sus resultados financieros y aspectos destacados del primer trimestre de 2025 el miércoles 23 de abril de 2025, a las 8:00 a.m. ET. La compañía publicará sus resultados financieros del Q1 antes de la llamada el mismo día.
La llamada de conferencia será dirigida por Mike Mahoney, presidente y CEO, junto a Dan Brennan, vicepresidente ejecutivo y CFO. Los inversores y partes interesadas pueden acceder a la transmisión en vivo y a la repetición a través del sitio web de relaciones con inversores de la compañía.
보스턴 사이언티픽 (NYSE: BSX)은 2025년 1분기 재무 결과 및 비즈니스 하이라이트에 대해 논의하기 위한 컨퍼런스 콜을 2025년 4월 23일 수요일 오전 8시 ET에 예정했습니다. 회사는 같은 날 통화 이전에 1분기 재무 결과를 발표할 예정입니다.
컨퍼런스 콜은 마이크 마호니 의장 겸 CEO와 댄 브레넌 수석 부사장 겸 CFO가 함께 진행합니다. 투자자 및 관심 있는 당사자는 회사의 투자자 관계 웹사이트를 통해 라이브 웹캐스트 및 재생을 이용할 수 있습니다.
Boston Scientific (NYSE: BSX) a prévu une conférence téléphonique pour discuter de ses résultats financiers et des points saillants du premier trimestre 2025 le mercredi 23 avril 2025 à 8h00 ET. L'entreprise publiera ses résultats financiers du Q1 avant l'appel le même jour.
La conférence téléphonique sera animée par Mike Mahoney, président et CEO, en collaboration avec Dan Brennan, vice-président exécutif et CFO. Les investisseurs et les parties intéressées peuvent accéder à la diffusion en direct et à la rediffusion via le site web des relations avec les investisseurs de l'entreprise.
Boston Scientific (NYSE: BSX) hat eine Telefonkonferenz angesetzt, um die finanziellen Ergebnisse und Geschäftshighlights des ersten Quartals 2025 am Mittwoch, den 23. April 2025, um 8:00 Uhr ET zu besprechen. Das Unternehmen wird die Finanzdaten des Q1 am selben Tag vor der Konferenz bekannt geben.
Die Telefonkonferenz wird von Mike Mahoney, Vorsitzender und CEO, zusammen mit Dan Brennan, Executive Vice President und CFO, geleitet. Investoren und Interessierte können über die Investor-Relations-Website des Unternehmens auf das Live-Webcast und die Wiederholung zugreifen.
- None.
- None.
A live webcast and replay for the event will be accessible at htts://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X.
CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com
Jon Monson
Investor Relations
+1 (508) 683-5450
BSXInvestorRelations@bsci.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-conference-call-discussing-first-quarter-2025-results-302415864.html
SOURCE Boston Scientific Corporation
FAQ
When will Boston Scientific (BSX) report Q1 2025 earnings?
How can investors access Boston Scientific's (BSX) Q1 2025 earnings call?
Who will host Boston Scientific's (BSX) Q1 2025 earnings call?
What period will Boston Scientific's (BSX) earnings report cover?
